BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19769600)

  • 21. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation.
    Påhlman LI; Olin AI; Darenberg J; Mörgelin M; Kotb M; Herwald H; Norrby-Teglund A
    Cell Microbiol; 2008 Feb; 10(2):404-14. PubMed ID: 17900297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of peptide-major histocompatibility complex tetramer technology to study interactions between Staphylococcus aureus proteins and human cells.
    Massey RC; Scriba TJ; Brown EL; Phillips RE; Sewell AK
    Infect Immun; 2007 Dec; 75(12):5711-5. PubMed ID: 17938227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural dichotomy of staphylococcal enterotoxin C superantigens leading to MHC class II-independent activation of T lymphocytes.
    Lamphear JG; Bohach GA; Rich RR
    J Immunol; 1998 Mar; 160(5):2107-14. PubMed ID: 9498747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins.
    Yagi J; Uchiyama T; Janeway CA
    J Immunol; 1994 Feb; 152(3):1154-62. PubMed ID: 7905498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
    Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
    Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
    Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
    Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
    Haas PJ; de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA; Dijkstra K; Scheek RM; Fan H; Kruijtzer JA; Liskamp RM; Kemmink J
    J Mol Biol; 2005 Nov; 353(4):859-72. PubMed ID: 16213522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell presentation of antigen requires cell-to-cell contact for proliferation and anergy induction. Differential MHC requirements for superantigen and autoantigen.
    LaSalle JM; Toneguzzo F; Saadeh M; Golan DE; Taber R; Hafler DA
    J Immunol; 1993 Jul; 151(2):649-57. PubMed ID: 7687620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
    Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
    J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The extracellular adherence protein from Staphylococcus aureus inhibits neutrophil binding to endothelial cells.
    Haggar A; Ehrnfelt C; Holgersson J; Flock JI
    Infect Immun; 2004 Oct; 72(10):6164-7. PubMed ID: 15385525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus.
    Xie C; Alcaide P; Geisbrecht BV; Schneider D; Herrmann M; Preissner KT; Luscinskas FW; Chavakis T
    J Exp Med; 2006 Apr; 203(4):985-94. PubMed ID: 16585266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Not every superantigen induces tolerance in vivo.
    Ochi A; Yuh K; Migita K
    Semin Immunol; 1993 Feb; 5(1):57-63. PubMed ID: 8467096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
    Papageorgiou AC; Tranter HS; Acharya KR
    J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells.
    Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA
    J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Superantigens and their importance for inflammatory skin diseases].
    Olsen JV; Skov L; Baadsgaard O
    Ugeskr Laeger; 1999 Aug; 161(34):4747-50. PubMed ID: 10500463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Staphyloccous aureus Eap protein activates expression of proinflammatory cytokines.
    Scriba TJ; Sierro S; Brown EL; Phillips RE; Sewell AK; Massey RC
    Infect Immun; 2008 May; 76(5):2164-8. PubMed ID: 18332207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.